| Literature DB >> 29085569 |
Davide Ippolito1, Alessandra Silvia Casiraghi1, Cammillo Talei Franzesi1, Davide Fior1, Franca Meloni2, Sandro Sironi2.
Abstract
AIM: To compare radiation dose and image quality of low-dose computed tomography (CT) protocol combined with hybrid-iterative reconstruction algorithm with standard-dose CT examinations for follow-up of oncologic patients.Entities:
Keywords: Computed tomography; Low-dose computed tomography; Oncologic imaging; Radiation dose; Tube current modulation
Year: 2017 PMID: 29085569 PMCID: PMC5648986 DOI: 10.4251/wjgo.v9.i10.423
Source DB: PubMed Journal: World J Gastrointest Oncol
Descriptive table of weight groups in the patients population (n = 51)
| Group A (41-60 kg) | 8 | 3/5 | 70.5 ± 8.6 |
| Group B (61-80 kg) | 25 | 9/16 | 67.6 ± 11.5 |
| Group C (81-90 kg) | 13 | 11/2 | 71.8 ± 7.4 |
| Group D ( > 90 kg) | 5 | 4/1 | 59.2 ± 10.1 |
| All patients | 51 | 34/18 | 68.3 ± 10.4 |
M: Male; F: Female.
Figure 1Axial contrast-enhanced computed tomography images at the level of upper abdomen obtained in a 81 years old female patient with lung cancer (height 160 cm, weight 61 kg). A: Standard dose protocol (120 kV, 300 mAs, DLP 1317.4 mGy*cm, CDTI 21.1 mGy); B: Lower dose protocol (120 kV, 142-222 mAs, DLP 846.0 mGy*cm, CDTI 13.6 mGy): Lower dose image shows increased sharpness and enhancement in comparison with standard dose image in spite of mild increase of noise, and similar diagnostic quality with a 35.8% Dose-Length-Product reduction.
Comparison of Dose-Length Product and Volumetric Computed Tomographic Dose Index obtained with standard-dose and low-dose protocols in all patients (n = 51) and according to weight (kg)
| Group A (41-60 kg) | 8 | 14.1 ± 0.0 | 9.8 ± 1.5 | 0.012 | 891.9 ± 36.3 | 627.5 ± 92.9 | 0.012 | 29.6 |
| Group B (61-80 kg) | 25 | 21.1 ± 0.0 | 14.0 ± 2.8 | < 0.001 | 1386.6 ± 65.9 | 920.0 ± 175.0 | < 0.001 | 33.5 |
| Group C (81-90 kg) | 13 | 24.6 ± 0.0 | 17.2 ± 2.9 | 0.001 | 1656.8 ± 61.2 | 1162.6 ± 204.2 | 0.001 | 29.9 |
| Group D ( > 90 kg) | 5 | 27.4 ± 1.5 | 26.5 ± 5.4 | 0.5 | 1910.4 ± 147.6 | 1835.1 ± 359.5 | 0.5 | 2.5 |
| All patients | 51 | 21.4 ± 4.0 | 15.4 ± 5.2 | < 0.001 | 1429.2 ± 297.7 | 1025.6 ± 370.9 | < 0.001 | 28.9 |
DLP: Dose-Length-Product; CTDIvol: Volumetric Computed Tomographic Dose Index.
Qualitative scoring of image noise, image sharpness and diagnostic quality of computed tomography images from Reader 1 and Reader 2
| Low-dosea | 3.4 ± 0.6 | 3.6 ± 0.6 | 3.7 ± 0.5 | 3.7 ± 0.5 | 3.7 ± 0.5 | 3.8 ± 0.4 |
| Group A ( | 3.6 ± 0.7 | 3.8 ± 0.5 | 3.6 ± 0.5 | 3.5 ± 0.5 | 3.9 ± 0.4 | 3.8 ± 0.5 |
| Group B ( | 3.4 ± 0.6 | 3.6 ± 0.6 | 3.8 ± 0.5 | 3.8 ± 0.4 | 3.7 ± 0.6 | 3.8 ± 0.4 |
| Group C ( | 3.1 ± 0.4 | 3.6 ± 0.5 | 3.6 ± 0.5 | 3.9 ± 0.4 | 3.6 ± 0.5 | 4.0 ± 0.0 |
| Group D ( | 3.3 ± 0.6 | 3.0 ± 1.0 | 4.0 ± 0.0 | 3.3 ± 0.6 | 4.0 ± 0.0 | 3.7 ± 0.6 |
| Standard-doseb | 3.6 ± 0.7 | 3.5 ± 0.6 | 3.3 ± 0.7 | 3.5 ± 0.6 | 3.7 ± 0.5 | 3.8 ± 0.4 |
| Group A ( | 3.9 ± 0.4 | 3.5 ± 0.5 | 3.1 ± 0.6 | 3.4 ± 0.5 | 3.9 ± 0.4 | 3.8 ± 0.5 |
| Group B ( | 3.7 ± 0.5 | 3.7 ± 0.5 | 3.5 ± 0.6 | 3.5 ± 0.6 | 3.8 ± 0.4 | 3.8 ± 0.4 |
| Group C ( | 3.3 ± 0.5 | 3.3 ± 0.5 | 2.9 ± 0.7 | 3.9 ± 0.4 | 3.6 ± 0.5 | 4.0 ± 0.0 |
| Group D ( | 2.3 ± 1.5 | 3.0 ± 1.0 | 3.0 ± 1.0 | 3.3 ± 0.6 | 2.7 ± 1.2 | 3.7 ± 0.6 |
| 0.292 | 0.655 | 0.012 | 0.088 | 0.437 | 0.206 | |
| k Cohen Reader 1-Reader 2 | 0.694a-0.756b | 0.783a-0.672b | 0.704a-0.786b | |||
Figure 2Axial contrast-enhanced computed tomography images at the level of upper abdomen obtained in a 70 years old female patient with ovarian cancer and some small hypoattenuating hepatic subcapsular implants with well-defined margins (height 160 cm, weight 68 kg). A: Standard dose protocol (120 kV, 300 mAs, Dose-Length-Product 1304.6 mGy*cm, CDTI 21.0 mGy); B: Lower dose protocol (120 kV, 123-231 mAs, Dose-Length-Product 840.9 mGy*cm, CDTI 13.1 mGy).
Computed tomography values (HU), standard deviation of computed tomography values (SD) and signal-to-noise ratio obtained with standard-dose and low-dose protocols
| HUaorta ( | 166.20 ± 18.83 | 154.17 ± 24.82 | < 0.001 |
| HUliver ( | 112.55 ± 16.49 | 103.90 ± 17.49 | < 0.001 |
| HUspleen ( | 126.24 ± 13.60 | 112.77 ± 15.66 | < 0.001 |
| SDliver ( | 16.81 ± 2.02 | 14.41 ± 3.33 | < 0.001 |
| SDspleen ( | 16.78 ± 2.04 | 14.72 ± 3.26 | < 0.001 |
| SDfat ( | 12.17 ± 2.77 | 12.07 ± 2.98 | 0.307 |
| SNRliver ( | 6.94 ± 1.32 | 7.80 ± 2.30 | 0.002 |
| SNRliver Group A ( | 8.09 ± 1.63 | 9.36 ± 2.27 | 0.05 |
| SNRliver Group B ( | 6.95 ± 1.22 | 8.53 ± 1.97 | < 0.001 |
| SNRliver Group C ( | 6.47 ± 1.00 | 6.66 ± 1.34 | 0.972 |
| SNRliver Group D ( | 6.29 ± 1.19 | 4.60 ± 1.77 | 0.08 |
| SNRspleen ( | 7.73 ± 1.46 | 8.10 ± 2.04 | 0.153 |
| SNRspleen Group A ( | 9.25 ± 2.31 | 10.53 ± 1.69 | 0.092 |
| SNRspleen Group B ( | 7.60 ± 1.10 | 8.04 ± 1.86 | 0.177 |
| SNRspleen Group C ( | 7.26 ± 1.11 | 7.20 ± 1.45 | 0.65 |
| SNRspleen Group D ( | 7.21 ± 0.82 | 6.86 ± 1.89 | 0.893 |
SNR: Signal-to-noise ratio.